Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors

BACKGROUND: Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both proteolytic enzymes are associated with poor prognosis in breast cancer patients. The purpose of this study was to evaluate the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Radiol Oncol
Asıl Yazarlar: Lampelj, Maja, Arko, Darja, Cas-Sikosek, Nina, Kavalar, Rajko, Ravnik, Maja, Jezersek-Novakovic, Barbara, Dobnik, Sarah, Dovnik, Nina Fokter, Takac, Iztok
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Versita, Warsaw 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4722926/
https://ncbi.nlm.nih.gov/pubmed/26834522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2014-0049
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller